Latest news and coverage on Drug Administration from across our reporting.
- FDA Panel Rejects MDMA Therapy for PTSD Citing Weak Evidence (2024-06-05)
- Experimental Oral Drug Daraxonrasib Targets KRAS in Pancreatic Cancer (2026-06-08)
- FDA Approves Lung Cancer Drug Lazertinib After 4-Year Lag (2024-08-16)
- FDA Approves First Drug Specifically for Children with Rare Brain Cancer (2024-04-22)
- Trump Signs Order to Maintain Existing Canada-U.S. Pipeline Operations (2026-04-18)
- FDA Approves First Pill for Slow-Growing Brain Cancer Treatment (2024-08-21)
- Thailand Reverses Cannabis Legalization After Teen Hospitalizations Triple (2024-02-29)
- Mutated Enzyme Target Yields Precision Drug for Two Cancers (2023-05-21)
- Nasdaq Tissue Firm Opens Lab to Target New Aesthetics Market Gap (2026-07-01)
- FDA Approves New Oral Pill Zuranolone for Postpartum Depression (2023-08-19)
- FDA Approves Alzheimer’s Drug Donanemab Despite 36.8% Brain Swelling Risk (2024-07-15)
- CRISPR Therapeutics Receives Regulatory Approval For Groundbreaking Treatment (2023-12-17)
- New Cancer Drug Delivered in Minutes Instead of Hours (2024-12-20)
